• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

告知注射吸毒者他们的丙型肝炎状况会影响其注射行为吗?网络II研究分析。

Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study.

作者信息

Aspinall E J, Weir A, Sacks-Davis R, Spelman T, Grebely J, Higgs P, Hutchinson S J, Hellard M E

机构信息

Glasgow Caledonian University, Glasgow, UK; Health Protection Scotland, Glasgow, UK.

Glasgow Caledonian University, Glasgow, UK; Health Protection Scotland, Glasgow, UK.

出版信息

Int J Drug Policy. 2014 Jan;25(1):179-82. doi: 10.1016/j.drugpo.2013.08.005. Epub 2013 Sep 8.

DOI:10.1016/j.drugpo.2013.08.005
PMID:24315504
Abstract

BACKGROUND

People who inject drugs (PWID) are at risk of hepatitis C virus (HCV). It is plausible that PWID who receive a diagnosis of HCV will reduce their injecting risk out of concern for their injecting partners, although evidence for this is currently limited. The aim of this study was to investigate whether informing PWID of their HCV diagnosis was associated with a change in injecting behaviour.

METHODS

Prospective, longitudinal study of PWID recruited from street drug markets across Melbourne, Australia. Interviews and HCV testing were conducted at 3-monthly intervals. The association between receiving a diagnosis of HCV and (i) injecting frequency and (ii) injecting equipment borrowing, was examined using generalized estimating equations (GEE) analysis.

RESULTS

Thirty-five individuals received a diagnosis of HCV during the study period. Receiving a diagnosis of HCV was associated with a decrease of 0.35 injections per month (p=0.046) but there was no change in injecting equipment borrowing (p=0.750).

CONCLUSIONS

A small reduction in injecting frequency was observed in PWID who received a diagnosis of HCV. This finding should be investigated further in larger studies examining a wider range of injecting risk behaviours.

摘要

背景

注射吸毒者(PWID)有感染丙型肝炎病毒(HCV)的风险。虽然目前这方面的证据有限,但有理由认为,被诊断出感染HCV的注射吸毒者出于对其注射伙伴的担忧,会降低其注射风险。本研究的目的是调查告知注射吸毒者其HCV诊断结果是否与注射行为的改变有关。

方法

对从澳大利亚墨尔本街头毒品市场招募的注射吸毒者进行前瞻性纵向研究。每隔三个月进行一次访谈和HCV检测。使用广义估计方程(GEE)分析来检验HCV诊断与(i)注射频率和(ii)借用注射设备之间的关联。

结果

在研究期间,有35人被诊断出感染HCV。HCV诊断与每月注射次数减少0.35次有关(p = 0.046),但借用注射设备的情况没有变化(p = 0.750)。

结论

在被诊断出感染HCV的注射吸毒者中,观察到注射频率略有下降。这一发现应在更大规模的研究中进一步调查,这些研究应考察更广泛的注射风险行为。

相似文献

1
Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study.告知注射吸毒者他们的丙型肝炎状况会影响其注射行为吗?网络II研究分析。
Int J Drug Policy. 2014 Jan;25(1):179-82. doi: 10.1016/j.drugpo.2013.08.005. Epub 2013 Sep 8.
2
Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C.注射毒品者在丙型肝炎病毒感染治疗后的注射风险行为:澳大利亚急性丙型肝炎试验
Int J Drug Policy. 2015 Oct;26(10):976-83. doi: 10.1016/j.drugpo.2015.05.003. Epub 2015 May 21.
3
A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs.一项关于丙型肝炎病毒检测及感染状况告知对注射吸毒者行为改变影响的纵向研究。
J Epidemiol Community Health. 2015 Aug;69(8):745-52. doi: 10.1136/jech-2014-205224. Epub 2015 Mar 26.
4
Modelling the prevalence of HCV amongst people who inject drugs: an investigation into the risks associated with injecting paraphernalia sharing.建模药物注射人群中丙型肝炎病毒(HCV)的流行率:对与共用注射器具相关的风险的调查。
Drug Alcohol Depend. 2013 Nov 1;133(1):172-9. doi: 10.1016/j.drugalcdep.2013.05.014. Epub 2013 Jun 20.
5
Use of respondent-driven sampling to enhance understanding of injecting networks: a study of people who inject drugs in Sydney, Australia.使用应答者驱动抽样增强对注射网络的理解:澳大利亚悉尼注射毒品者研究。
Int J Drug Policy. 2011 Jul;22(4):267-73. doi: 10.1016/j.drugpo.2011.03.007. Epub 2011 May 7.
6
Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study.在接受丙型肝炎病毒感染治疗期间和之后,注射吸毒者的风险行为变化:ACTIVATE 研究。
Int J Drug Policy. 2017 Sep;47:230-238. doi: 10.1016/j.drugpo.2017.05.040. Epub 2017 Jun 19.
7
Short-term injection drug use changes following hepatitis C virus (HCV) assessment and treatment among persons who inject drugs with acute HCV infection.急性 HCV 感染的吸毒者接受 HCV 评估和治疗后短期药物注射使用的变化。
Int J Drug Policy. 2017 Sep;47:239-243. doi: 10.1016/j.drugpo.2017.05.033. Epub 2017 Jun 4.
8
Sustained drug use changes after hepatitis C screening and counseling among recently infected persons who inject drugs: a longitudinal study.丙型肝炎筛查和咨询后,近期注射吸毒者的持续药物使用变化:一项纵向研究。
Clin Infect Dis. 2014 Mar;58(6):755-61. doi: 10.1093/cid/cit938. Epub 2013 Dec 20.
9
Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.2005-2012 年旧金山注射吸毒人群中针具来源和共用趋势。
Int J Drug Policy. 2015 Dec;26(12):1238-43. doi: 10.1016/j.drugpo.2015.08.013. Epub 2015 Aug 22.
10
Impact of Hepatitis C treatment on behavioural change in relation to drug use in people who inject drugs: A systematic review.丙型肝炎治疗对注射吸毒者药物使用相关行为改变的影响:系统评价。
Int J Drug Policy. 2019 Oct;72:169-176. doi: 10.1016/j.drugpo.2019.05.011. Epub 2019 May 18.

引用本文的文献

1
Individual Heterogeneity and Trends in Hepatitis C Infection Risk Among People Who Inject Drugs: A Longitudinal Analysis.注射吸毒者中丙型肝炎感染风险的个体异质性和趋势:一项纵向分析
J Viral Hepat. 2025 Apr;32(4):e13999. doi: 10.1111/jvh.13999. Epub 2024 Sep 5.
2
Novel Routes of Potential Hepatitis C Virus Transmission among People Who Inject Drugs: Secondary Blood Exposures Related to Injection Drug Use.新型潜在丙型肝炎病毒传播途径:与注射吸毒相关的次要血液暴露。
Subst Use Misuse. 2021;56(6):751-757. doi: 10.1080/10826084.2021.1879149. Epub 2021 Mar 26.
3
High-risk behaviors and their association with awareness of HIV status among participants of a large-scale prevention intervention in Athens, Greece.
在希腊雅典进行的一项大规模预防干预措施中,参与者的高危行为及其与艾滋病病毒感染状况知晓率的关系。
BMC Public Health. 2020 Jan 28;20(1):105. doi: 10.1186/s12889-020-8178-y.
4
High prevalence of hepatitis C virus infection and low level of awareness among people who recently started injecting drugs in a cross-sectional study in Germany, 2011-2014: missed opportunities for hepatitis C testing.横断面研究显示,2011-2014 年德国新开始注射吸毒人群中丙型肝炎病毒感染率高,知晓率低:丙型肝炎检测机会错失。
Harm Reduct J. 2020 Jan 10;17(1):7. doi: 10.1186/s12954-019-0338-y.
5
Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.监禁史与注射吸毒人群中 HIV 和丙型肝炎病毒感染风险:系统评价和荟萃分析。
Lancet Infect Dis. 2018 Dec;18(12):1397-1409. doi: 10.1016/S1473-3099(18)30469-9. Epub 2018 Oct 29.
6
Hepatitis C virus prevention and care for drug injectors: the French approach.丙型肝炎病毒对药物注射者的预防与护理:法国的方法。
Hepatol Med Policy. 2018 Jun 5;3:7. doi: 10.1186/s41124-018-0033-8. eCollection 2018.
7
Concordance between self-reported and measured HIV and hepatitis C virus infection status among people who inject drugs in Germany.德国注射吸毒者自我报告的与检测出的艾滋病毒和丙型肝炎病毒感染状况之间的一致性。
Hepatol Med Policy. 2016 Sep 1;1:8. doi: 10.1186/s41124-016-0016-6. eCollection 2016.
8
Families Living with Blood-Borne Viruses: The Case for Extending the Concept of "Serodiscordance".与血源病毒共存的家庭:扩展“血清学不一致”概念的理由
Interdiscip Perspect Infect Dis. 2017;2017:4352783. doi: 10.1155/2017/4352783. Epub 2017 Oct 18.
9
Injection Partners, HCV, and HIV Status among Rural Persons Who Inject Drugs in Puerto Rico.波多黎各农村地区注射毒品者的注射伙伴、丙型肝炎病毒和艾滋病病毒感染状况
Subst Use Misuse. 2018 Jun 7;53(7):1128-1138. doi: 10.1080/10826084.2017.1400562. Epub 2017 Nov 22.
10
Direct-acting antiviral agents for HCV infection affecting people who inject drugs.直接作用抗病毒药物治疗影响注射吸毒人群的 HCV 感染。
Nat Rev Gastroenterol Hepatol. 2017 Nov;14(11):641-651. doi: 10.1038/nrgastro.2017.106. Epub 2017 Aug 23.